HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate Wields Enamel Health To Gain Toothpaste Market Share

This article was originally published in The Rose Sheet

Executive Summary

The launch marks the only enamel-centered toothpaste in Colgate’s U.S. portfolio. The firm says 54% of consumers are concerned about weakened tooth enamel.

You may also be interested in...



Unilever’s “Mature” Personal-Care Biz Inspires Confidence Despite Economy

M&A activity and organic growth have grown Unilever’s personal-care unit into a “mature” business that is gaining share globally while transforming the firm’s U.S. presence, CEO Polman said during a July 24 first-half earnings call. Still, the Anglo-Dutch firm’s personal-care sector struggled in the unstable global environment, with turnover dipping 5.5% in the first half.

Light At End of Tunnel As Some Conferences Reschedule, But Lights Off For Others In 2020

CHPA’s Regulatory, Scientific & Quality Conference rescheduled for 1-2 September and the Dietary Supplements Regulatory Summit for 16 September. Several spring conferences canceled due to Covid-19 will not be rescheduled, groups say.

Supplement Firms Should Tighten Supply Gatekeeping As FDA Suspends Inspections

Supplement manufacturers should increase vigilance over supply chains after FDA suspends routine facility inspections and certain requirements of its foreign supplier verification program. Firms should verify even their trusted supplier’s next few certificates of analysis and step-up adverse event monitoring.

Related Companies

UsernamePublicRestriction

Register

RS019153

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel